A detailed history of Financial Gravity Asset Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 26,357 shares of AZN stock, worth $1.79 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
26,357
Previous 22,647 16.38%
Holding current value
$1.79 Million
Previous $1.53 Billion 34.7%
% of portfolio
0.51%
Previous 0.43%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$66.81 - $80.83 $247,865 - $299,879
3,710 Added 16.38%
26,357 $2.05 Billion
Q1 2024

Jun 26, 2024

SELL
$61.03 - $69.57 $854 - $973
-14 Reduced 0.06%
22,647 $1.53 Billion
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $1.53 Million - $1.74 Million
25,011 Added 33348.0%
25,086 $1.7 Billion
Q4 2023

Jun 26, 2024

SELL
$61.89 - $69.28 $150,083 - $168,004
-2,425 Reduced 9.67%
22,661 $1.53 Billion
Q3 2023

Nov 15, 2023

BUY
$64.85 - $71.7 $194 - $215
3 Added 4.17%
75 $5,000
Q2 2023

Aug 08, 2023

BUY
$69.91 - $75.81 $209 - $227
3 Added 4.35%
72 $6.73 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $63 - $71
1 Added 1.47%
69 $1.61 Million
Q4 2022

Feb 15, 2023

SELL
$54.21 - $70.44 $32,092 - $41,700
-592 Reduced 89.7%
68 $6.2 Million
Q3 2022

Nov 03, 2022

SELL
$53.02 - $135.75 $27,994 - $71,676
-528 Reduced 44.44%
660 $1.27 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $4,791 - $5,772
86 Added 7.8%
1,188 $1.54 Million
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $58,287 - $68,872
1,079 Added 4691.3%
1,102 $1.36 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $1,222 - $1,337
22 Added 2200.0%
23 $60,000
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $47 - $54
-1 Reduced 50.0%
1 $30,000
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $97 - $116
2 New
2 $0
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $344 - $442
-8 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$37.79 - $51.33 $1,473 - $2,001
-39 Reduced 82.98%
8 $0
Q4 2019

Feb 28, 2020

BUY
$42.46 - $50.46 $849 - $1,009
20 Added 74.07%
47 $50,000
Q3 2019

Oct 15, 2019

SELL
$40.12 - $45.47 $1,203 - $1,364
-30 Reduced 52.63%
27 $1,000
Q2 2019

Jul 26, 2019

SELL
$37.28 - $41.68 $1,379 - $1,542
-37 Reduced 39.36%
57 $2,000
Q1 2019

Apr 19, 2019

BUY
$35.49 - $43.02 $603 - $731
17 Added 22.08%
94 $4,000
Q3 2018

Oct 31, 2018

BUY
$34.76 - $39.72 $347 - $397
10 Added 14.93%
77 $3,000
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $241 - $259
-7 Reduced 9.46%
67 $3,000
Q1 2018

May 23, 2018

BUY
$32.97 - $36.63 $2,439 - $2,710
74 New
74 $3,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.